Physician profile
Grace E Mccracken
NPI 1659856300
$2,177.59
in general payments reported to CMS, 2019-2025
20 companies · $650 in 2025
The $650 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $333 · 2023: $817 · 2024: $377 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,844.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amphastar Pharmaceuticals, INC. | $384.70 | 2024-2025 | |
| Lilly USA, LLC | $252.48 | 2022-2025 | Mounjaro, Jardiance, Trulicity |
| Amgen INC. | $222.82 | 2023-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $198.48 | 2023-2024 | |
| Exact Sciences Corporation | $177.78 | 2023-2025 | Cologuard Collection Kit |
| Madrigal Pharmaceuticals | $170.03 | 2025 | Rezdiffra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $154.90 | 2022-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.82 | 2022-2024 | Jardiance |
| Axsome Therapeutics, INC. | $99.79 | 2023 | Auvelity |
| Sumitomo Pharma America, INC. | $70.67 | 2023 | Gemtesa |
| Sanofi Pasteur INC. | $68.06 | 2023-2024 | |
| Idorsia Pharmaceuticals US INC | $58.34 | 2022-2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $29.41 | 2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $27.61 | 2023 | Xarelto |
| Lundbeck LLC | $25.77 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $22.69 | 2025 | Nimbl, Flexitouch Plus |
| Medtronic, INC. | $22.49 | 2024 | Inpen Smart Insulin Delivery System |
| Beta Bionics, INC. | $19.41 | 2024 | Ilet Bionic Pancreas |
| Grifols USA, LLC | $18.42 | 2023 | Prolastin-C Liquid |
| Amarin Pharma, INC. | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Mccracken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.